Document Detail

Obstructive sleep apnea syndrome is related to the progression of chronic kidney disease.
MedLine Citation:
PMID:  21369754     Owner:  NLM     Status:  Publisher    
BACKGROUND AND AIM: Obstructive sleep apnea syndrome (OSAS) is an independent risk factor for the development of cardiovascular events and hypertension. The possible causes are oxygen desaturation due to hypopnea, increased cytokine levels and insulin resistance. All these risk factors also have a role in the progression of chronic kidney disease (CKD). The aim of this study was to determine the relationship between OSAS and the severity of CKD. MATERIALS AND METHODS: We retrospectively evaluated the medical records of 175 subjects who were admitted for the polysomnography study. OSAS was diagnosed by polysomnography if Apnea-Hypopnea Index (AHI) > 5 and glomerular filtration rate (GFR) was calculated with Cockcroft-Gault formula. According to AHI, individuals with AHI < 5 were recruited as group 1 (OSAS negative group), those with AHI = 5-15 group 2 (mild OSAS group), those with AHI = 15-30 group 3 (moderate OSAS group), and those with AHI > 30 group 4 (severe OSAS group). RESULTS: Of the subjects, 117 (67%) were men, 58 (33%) were women and the mean age was 54.0 ± 12.1 years. There were 28 (14.3%), 18 (10.3%), 35 (20.0%) and 97 (55.4%) patients in groups 1, 2, 3 and 4 respectively. The prevalence of diabetes mellitus and hypertension and body mass index was significantly higher in severe OSAS group (P < 0.05). A significant decrease in GFR was detected when the severity of OSAS increased (group 1 = 50.0 ± 11.8, group 2 = 44.8 ± 15.9, group 3 = 40.8 ± 14.7, group 4 = 38.8 ± 16.0; P for trend < 0.001). CONCLUSION: In the light of the present study, we speculate that OSAS is an independent risk factor for the progression of chronic kidney disease, which is a growing health problem. Further randomized-multicenter prospective studies are warranted to evaluate this relationship.
Asiye Kanbay; Hakan Buyukoglan; Nezihe Ozdogan; Elif Kaya; Fatma Sema Oymak; Inci Gulmez; Ramazan Demir; Oguz Kokturk; Adrian Covic
Related Documents :
21313904 - Comparison the effects of metoclopramide and dropridol associated with dexamethasone on...
21398574 - Prospective, randomized, multicenter food and drug administration investigational devic...
9531434 - Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion in very...
21344494 - The efficacy of additive tolterodine extended release for 1-year in older men with stor...
22419354 - Single-incision apical and posterior mesh repair: 1-year prospective outcomes.
10796584 - Mecamylamine (a nicotine antagonist) for smoking cessation.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-3
Journal Detail:
Title:  International urology and nephrology     Volume:  -     ISSN:  1573-2584     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0262521     Medline TA:  Int Urol Nephrol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Pulmonary Medicine, Erciyes University School of Medicine, Kayseri, Turkey,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects...
Next Document:  Optimization and development of analytical methods for the determination of new brominated flame ret...